advertisement
Maruyama K 6
Showing records 1 to 6 | Display all abstracts from Maruyama K59533 Retinal transcriptome profiling at transcription start sites: a cap analysis of gene expression early after axonal injury
Yasuda M; Tanaka Y; Nishiguchi KM; Ryu M; Tsuda S; Maruyama K; Nakazawa T
BMC Genomics 2014; 15: 982
59108 Topographical Correlation Between Macular Layer Thickness and Clockwise Circumpapillary Retinal Nerve Fiber Layer Sectors in Patients with Normal Tension Glaucoma
Omodaka K; Yokoyama Y; Shiga Y; Inoue M; Takahashi S; Tsuda S; Maruyama K; Nakazawa T
Current Eye Research 2014; 0: 1-8
59637 Characteristics of uveitic glaucoma and evaluation of its surgical treatment
Shimizu A; Maruyama K; Yokoyama Y; Tsuda S; Ryu M; Nakazawa T
Clinical Ophthalmology 2014; 8: 2383-2389
59266 The Novel Rho Kinase (ROCK) Inhibitor K-115: A New Candidate Drug for Neuroprotective Treatment in Glaucoma
Yamamoto K; Maruyama K; Himori N; Omodaka K; Yokoyama Y; Shiga Y; Morin R; Nakazawa T
Investigative Ophthalmology and Visual Science 2014; 55: 7126-7136
59003 Neuroprotective effect against axonal damage-induced retinal ganglion cell death in apolipoprotein E-deficient mice through the suppression of kainate receptor signaling
Omodaka K; Nishiguchi KM; Yasuda M; Tanaka Y; Sato K; Nakamura O; Maruyama K; Nakazawa T
Brain Research 2014; 1586: 203-212
59356 Incidence of Postoperative Ptosis Following Trabeculectomy With Mitomycin C
Naruo-Tsuchisaka A; Maruyama K; Arimoto G; Goto H
Journal of Glaucoma 2015; 24: 417-420